BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24422878)

  • 1. Genome sequencing and characterization of an extensively drug-resistant sequence type 111 serotype O12 hospital outbreak strain of Pseudomonas aeruginosa.
    Witney AA; Gould KA; Pope CF; Bolt F; Stoker NG; Cubbon MD; Bradley CR; Fraise A; Breathnach AS; Butcher PD; Planche TD; Hinds J
    Clin Microbiol Infect; 2014 Oct; 20(10):O609-18. PubMed ID: 24422878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outbreak of carbapenem-resistant Pseudomonas aeruginosa producing VIM-8, a novel metallo-beta-lactamase, in a tertiary care center in Cali, Colombia.
    Crespo MP; Woodford N; Sinclair A; Kaufmann ME; Turton J; Glover J; Velez JD; Castañeda CR; Recalde M; Livermore DM
    J Clin Microbiol; 2004 Nov; 42(11):5094-101. PubMed ID: 15528701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
    Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
    J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-Resolution Analysis by Whole-Genome Sequencing of an International Lineage (Sequence Type 111) of Pseudomonas aeruginosa Associated with Metallo-Carbapenemases in the United Kingdom.
    Turton JF; Wright L; Underwood A; Witney AA; Chan YT; Al-Shahib A; Arnold C; Doumith M; Patel B; Planche TD; Green J; Holliman R; Woodford N
    J Clin Microbiol; 2015 Aug; 53(8):2622-31. PubMed ID: 26041902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outbreak of multidrug-resistant Pseudomonas aeruginosa in an intensive care unit.
    Durojaiye OC; Carbarns N; Murray S; Majumdar S
    J Hosp Infect; 2011 Jun; 78(2):154-5. PubMed ID: 21507523
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of Carbapenem Resistance in Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from a Croatian Hospital.
    Bubonja-Sonje M; Matovina M; Skrobonja I; Bedenic B; Abram M
    Microb Drug Resist; 2015 Jun; 21(3):261-9. PubMed ID: 25565041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, microbiologic, and epidemiologic characteristics of Pseudomonas aeruginosa infections in a University Hospital, Malatya, Turkey.
    Yetkin G; Otlu B; Cicek A; Kuzucu C; Durmaz R
    Am J Infect Control; 2006 May; 34(4):188-92. PubMed ID: 16679175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nosocomial spread of class 1 integron-carrying extensively drug-resistant Pseudomonas aeruginosa isolates in a Thai hospital.
    Kiddee A; Henghiranyawong K; Yimsabai J; Tiloklurs M; Niumsup PR
    Int J Antimicrob Agents; 2013 Oct; 42(4):301-6. PubMed ID: 23845503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of a nosocomial outbreak by alginate-producing pan-antibiotic-resistant Pseudomonas aeruginosa.
    Yakupogullari Y; Otlu B; Dogukan M; Gursoy C; Korkmaz E; Kizirgil A; Ozden M; Durmaz R
    Am J Infect Control; 2008 Dec; 36(10):e13-8. PubMed ID: 19084158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole Genome Sequencing in Real-Time Investigation and Management of a Pseudomonas aeruginosa Outbreak on a Neonatal Intensive Care Unit.
    Davis RJ; Jensen SO; Van Hal S; Espedido B; Gordon A; Farhat R; Chan R
    Infect Control Hosp Epidemiol; 2015 Sep; 36(9):1058-64. PubMed ID: 26050101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological investigation of Pseudomonas aeruginosa isolates from a six-year-long hospital outbreak using high-throughput whole genome sequencing.
    Snyder LA; Loman NJ; Faraj LA; Levi K; Weinstock G; Boswell TC; Pallen MJ; Ala'Aldeen DA
    Euro Surveill; 2013 Oct; 18(42):. PubMed ID: 24176582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular evolution of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a nosocomial setting of high-level endemicity.
    Lagatolla C; Edalucci E; Dolzani L; Riccio ML; De Luca F; Medessi E; Rossolini GM; Tonin EA
    J Clin Microbiol; 2006 Jul; 44(7):2348-53. PubMed ID: 16825348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Phenotypic and genotypic (randomly amplified polymorphic DNA analysis and multiple-locus variable-number tandem-repeat analysis) charaterization of 96 clinical isolates of Pseudomonas aeruginosa in the F. Bourguiba hospital (Monastir, Tunisia)].
    Ben Haj Khalifa A; Vu-Thien H; Pourcel C; Khedher M; Mastouri M; Moissenet D
    Pathol Biol (Paris); 2010 Feb; 58(1):84-8. PubMed ID: 19892484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular epidemiology of outbreaks and containment of drug-resistant Pseudomonas aeruginosa in a Tokyo hospital.
    Sekiguchi J; Teruya K; Horii K; Kuroda E; Konosaki H; Mizuguchi Y; Araake M; Kawana A; Yoshikura H; Kuratsuji T; Miyazaki H; Kirikae T
    J Infect Chemother; 2007 Dec; 13(6):418-22. PubMed ID: 18095093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic variations between colistin-susceptible and -resistant Pseudomonas aeruginosa clinical isolates and their effects on colistin resistance.
    Lee JY; Na IY; Park YK; Ko KS
    J Antimicrob Chemother; 2014 May; 69(5):1248-56. PubMed ID: 24474431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiological investigation of Pseudomonas aeruginosa nosocomial bacteraemia isolates by PCR-based DNA fingerprinting analysis.
    Liu Y; Davin-Regli A; Bosi C; Charrel RN; Bollet C
    J Med Microbiol; 1996 Nov; 45(5):359-65. PubMed ID: 8918952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of a long-term outbreak of XDR Pseudomonas aeruginosa: a molecular epidemiological study.
    Willmann M; Bezdan D; Zapata L; Susak H; Vogel W; Schröppel K; Liese J; Weidenmaier C; Autenrieth IB; Ossowski S; Peter S
    J Antimicrob Chemother; 2015 May; 70(5):1322-30. PubMed ID: 25583750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of interventional molecular epidemiology in controlling clonal clusters of multidrug resistant Pseudomonas aeruginosa in critically ill cancer patients.
    Adachi JA; Perego C; Graviss L; Dvorak T; Hachem R; Chemaly RF; Raad II
    Am J Infect Control; 2009 Aug; 37(6):442-6. PubMed ID: 19118923
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surveillance of Pseudomonas aeruginosa in intensive care units: clusters of nosocomial cross-infection and encounter of a multiple-antibiotic resistant strain.
    Traub WH; Scheidhauer R; Leonhard B; Bauer D
    Chemotherapy; 1998; 44(4):243-59. PubMed ID: 9681201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic surveillance, characterization and intervention of a polymicrobial multidrug-resistant outbreak in critical care.
    Roberts LW; Forde BM; Hurst T; Ling W; Nimmo GR; Bergh H; George N; Hajkowicz K; McNamara JF; Lipman J; Permana B; Schembri MA; Paterson D; Beatson SA; Harris PNA
    Microb Genom; 2021 Mar; 7(3):. PubMed ID: 33599607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.